Texas Oncology - Baylor Charles A. Simmons Cancer Center

Dallas, Texas 75246

We've found

4 trials

at this facility

An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Dallas, TX

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Dallas, TX

An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Dallas, TX

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986253 Given in Combination With Nivolumab in Patients With Advanced Cancers

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Dallas, TX

Use our guide to learn which trials are right for you!